Eli Lilly has now submitted a new drug application (NDA) for GLP-1RA orforglipron to the FDA for use in adults with obesity.

Shares in Tokyo-listed Nxera Pharma slid 5% at market open after Boehringer walked away from the neurological assets.

Dr. Eva-Maria Hempe, NVIDIA, looks back at 2025 and ahead to 2026, noting that AI accelerates pharma overall, particularly in ...

Mandy Vink, VP of Business Development at Codexis, explains how the company leverages over 20 years of expertise in small-molecule APIs to advance biocatalysis across pharma.

AI has the potential to transform pharmaceutical supply chains by enhancing visibility and predicting disruptions. Traditional supply chains often suffer from a lack of transparency, making it ...

In the complex world of pharmaceutical manufacturing, pharma tech transfers – the process of moving manufacturing operations between facilities or phases – can present significant challenges. A recent ...

Turbiscan technology accelerates lipid nanoparticle stability testing and supports robust pharmaceutical formulation ...

As the world prepares for long-term human missions to the Moon and Mars, researchers from Sunway University and Monash ...

Ember LifeSciences is moving quickly to turn fresh capital into cold-chain scale. The healthcare logistics technology company ...

Goldman Sachs Group Inc. expects M&A activity in Italy to continue to expand in 2026, driven by banks, technology, telecom ...

Clever Culture is quietly automating one of pharma’s most unforgiving jobs , turning a regulatory headache into a scalable ...

AI tools have emerged as a transformative technology to help spot or avert any potential disruptions in the global ...